Alogliptin-Induced Minimal Change Nephrotic Syndrome and Interstitial Nephritis-Reference-Cited by-同舟云学术

Alogliptin-Induced Minimal Change Nephrotic Syndrome and Interstitial Nephritis

Published:2019-03 Issue:2 Volume:1 Page:75-78
ISSN:2590-0595
Container-title:Kidney Medicine
language:en
Short-container-title:Kidney Medicine

Author:

Shima Hisato^ORCID,Okamoto Takuya,Tashiro Manabu,Inoue Tomoko,Masaki Chiaki,Tada Hiroaki,Takamatsu Norimichi,Kawahara Kazuhiko,Okada Kazuyoshi,Doi Toshio,Minakuchi Jun,Kawashima Shu

Publisher

Elsevier BV

Subject

Nephrology,Internal Medicine

Reference20 articles.

1. Alogliptin: a new dipeptidyl peptidase-4 inhibitor for type 2 diabetes mellitus;Jarvis;Ann Pharmacother,2013

2. Effectiveness and safety of dipeptidyl peptidase 4 inhibitors in the management of type 2 diabetes in older adults: a systematic review and development of recommendations to reduce inappropriate prescribing;Schott;BMC Geriatr,2017

3. Alogliptin (Nesina) for adults with type-2 diabetes;Dineen;Pharm Ther,2014

4. Secondary minimal change disease;Glassock;Nephrol Dial Transplant,2003

5. Granulomatous interstitial nephritis;Joss;Clin J Am Soc Nephrol,2007

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alogliptina y nefritis tubulointersticial: una complicación potencial;Nefrología;2024-09

2. Antidiabetic Medication-Induced Acute Interstitial Nephritis: Case Report and Literature Search;British Journal of Diabetes;2021-12-08

3. A Case of Acute Interstitial Nephritis After Two Doses of the BNT162b2 SARS-CoV-2 Vaccine;International Journal of Nephrology and Renovascular Disease;2021-12

4. Alogliptin;Reactions Weekly;2019-08